COLM MCCAULEY: Open Payments
NPI 1518980531 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 31 payments from 14 companies in 2025. Trend: 2023 $807 · 2024 $1,113 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $246 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Astellas Pharma US Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $44 |
| Exact Sciences Corporation | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Antares Pharma, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: FARXIGA, XIFAXAN, Veozah, BREZTRI, Cologuard Collection Kit, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across OK — which companies pay providers there.
